Success Treatment of Severe and Active Graves' Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
We report a woman, 45th year old with Graves' disease treated with anti-thyroid drug (thiamazole). She came to our clinic with severe and active Graves' orbitopathy. We treated her with high dose intravenous methylprednisolone weekly (0.5 g weekly/ 6 weeks) and mycophenolate sodium 0.72 g...
Saved in:
Main Author: | Laurentius Aswin Pramono (Author) |
---|---|
Format: | Book |
Published: |
Interna Publishing,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves' Orbitopathy
by: Jun Jia, et al.
Published: (2022) -
IgG4 as a Biomarker in Graves' Orbitopathy
by: Michał Olejarz, et al.
Published: (2021) -
Current Diagnosis and Management of Graves' Disease
by: Imam Subekti, et al.
Published: (2018) -
Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison
by: Dujana Mostafa Hamed, et al.
Published: (2021) -
Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study
by: Bogusz Falkowski, et al.
Published: (2020)